Gary S Ott

Title: Gary S. Ott: Innovator in Monoclonal Antibody Purification

Introduction

Gary S. Ott is a notable inventor based in Livermore, CA, who has made significant contributions to the field of biotechnology. He holds 2 patents that focus on innovative methods for the purification of monoclonal antibodies, which are crucial in various medical and research applications.

Latest Patents

One of his latest patents is titled "Use of Hydroxylapatite for the Analysis and Preparation of Purified." This novel method discloses a purification technique for monoclonal antibodies from antibodies of the same isotype but different light chain composition. These antibodies are often present in the fluids where they are generated. The method involves placing the mixture in a hydroxylapatite chromatography column and eluting it with a buffer solution in a concentration gradient. With appropriate optimization of system parameters, effective separation of antibodies for both analytical and preparative purposes is achieved.

Another significant patent by Gary Ott is "Process for Binding IgG to Protein A." This patent describes an unusually strong binding of IgG to protein A, achieved by contacting these components in a medium with a high concentration of salt. This binding has general utility, but it is particularly useful for purifying monoclonal antibodies from ascites fluid through affinity chromatography.

Career Highlights

Gary S. Ott is currently associated with Bio-Rad Laboratories, Inc., a leading company in the life sciences industry. His work at Bio-Rad has allowed him to focus on developing innovative solutions for antibody purification, contributing to advancements in research and therapeutic applications.

Collaborations

Throughout his career, Gary has collaborated with notable colleagues, including Hector Juarez-Salinas and Sheldon C. Engelhorn. These collaborations have further enhanced the impact of his work in the field of biotechnology.

Conclusion

Gary S. Ott is a distinguished inventor whose work in monoclonal antibody purification has paved the way for advancements in biotechnology. His innovative patents and contributions to Bio-Rad Laboratories, Inc. highlight his commitment to improving research methodologies.